Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions.

AMPULLARY & DUODENAL CANCER
Disease Spotlight & Research Roundtable

Ampullary and duodenal cancers are rare malignancies of the gastrointestinal tract, for which current treatment paradigms remain borrowed from nearby and/or related malignancies of the pancreas and colon, respectively. Clinical outcomes from ampullary and duodenal cancers, however, are distinct, reflecting genomic drivers that are unique to these cancer types. Survival from these malignancies are quite poor, highlighting the need for preclinical model development and translational studies that define specific molecular vulnerabilities to nominate effective clinical interventions.

During this VRCC Roundtable, we will hear from a panel of experts to articulate our current understanding of these rare tumor types, recent advances in clinical treatment and genomic characterization, and collaborative opportunities to advance the field further.

Speakers

• 

  Rohit Chandwani, MD, PhD

  Assistant Professor of Medicine
  Division of Liver Transplantation, Hepatobiliary & Pancreatic Surgery
  Department of Surgery
  Department of Cell and Developmental Biology
  Sandra and Edward Meyer Cancer Center
  Weill Cornell Medicine

• 

  Brett Ecker, MD

  Clinical Fellow
  Memorial Sloan Kettering Cancer Center

• 

  Arvind Rishi, MD, FCAP

  Associate Professor, Donald Barbara Zucker School of Medicine at Hofstra/Northwell Health
  Gastrointestinal and Hepatobiliary Pathologist
  Medical Director, Northwell Health Biospecimen Repository (NHBR)
  Northwell Health Laboratories